Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 44

Results For "Road"

1292 News Found

Aster DM Healthcare to build Rs. 580 crore crore hospital in Bengaluru
Healthcare | August 05, 2025

Aster DM Healthcare to build Rs. 580 crore crore hospital in Bengaluru

This will be Aster’s fifth hospital in Bengaluru


Illumina launches new assay for tumor profiling
News | August 03, 2025

Illumina launches new assay for tumor profiling

he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements


iPHEX 2025 to showcase India’s pharmaceutical and healthcare power on Sept 4-6, 2025
News | August 01, 2025

iPHEX 2025 to showcase India’s pharmaceutical and healthcare power on Sept 4-6, 2025

A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide


Rise of Bio-based Chemicals: Hype or Game-Changer?: Dr. Sangeeta Srivastava, Executive Director, Godavari Biorefineries
Opinion | July 28, 2025

Rise of Bio-based Chemicals: Hype or Game-Changer?: Dr. Sangeeta Srivastava, Executive Director, Godavari Biorefineries

The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production


GSK forges $12 billion alliance with Hengrui Pharma
News | July 28, 2025

GSK forges $12 billion alliance with Hengrui Pharma

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology


Roche provides update on astegolimab in chronic obstructive pulmonary disease
Clinical Trials | July 21, 2025

Roche provides update on astegolimab in chronic obstructive pulmonary disease

The phase III ARNASA study did not meet the primary endpoint of a statistically significant reduction in the AER at 52 weeks


Aarti Drugs posts Q1 FY26 PAT higher at Rs. 54 Cr
News | July 21, 2025

Aarti Drugs posts Q1 FY26 PAT higher at Rs. 54 Cr

During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D


Bayer’s Nubeqa receives EU approval for patients with advanced prostate cancer
Drug Approval | July 21, 2025

Bayer’s Nubeqa receives EU approval for patients with advanced prostate cancer

European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)


Plant-based chemistry essential for home and personal care products:  Vishal Sharma, Executive Director & Chief Executive Officer (Chemicals), Godrej Industries
Opinion | July 17, 2025

Plant-based chemistry essential for home and personal care products: Vishal Sharma, Executive Director & Chief Executive Officer (Chemicals), Godrej Industries

Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products